Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
03/2009
03/19/2009WO2009034258A1 Tri-amino-pyrimidine cyclobutenedione derivatives used as phosphatase cdc25 inhibitors
03/19/2009WO2005076861A3 Compounds that inhibit hiv particle formation
03/19/2009US20090076271 Process for preparing intermediates of HMG-CoA reductase inhibitors
03/19/2009US20090076047 2-Substituted Hydroxylaminopyrimidine, Method for the Production and the Use Thereof in the Form of Pesticides
03/19/2009US20090076046 Compounds modulating c-fms and/or c-kit activity and uses therefor
03/19/2009US20090076045 Non-nucleoside reverse transcriptase inhibitors
03/19/2009US20090076044 Vegfr inhibitors containing a zinc binding moiety
03/19/2009US20090076043 Deuterium-enriched alfuzosin
03/19/2009US20090076042 Deuterium-enriched erlotinib
03/19/2009US20090076030 Piperazine compounds
03/19/2009US20090076022 Tartrate salts of quinazoline based egfr inhibitors containing a zinc binding moiety
03/19/2009US20090076005 Kinase inhibitor compounds
03/19/2009US20090075986 Anti-inflammatory medicaments
03/19/2009US20090075982 Piperazine compounds
03/19/2009US20090075939 Novel HIV reverse transcriptase inhibitors
03/19/2009US20090074887 For control of phytopathogenic fungi; synergistic
03/19/2009CA2698944A1 Tartrate salts or complexes of quinazoline based egfr inhibitors containing a zinc binding moiety
03/19/2009CA2692702A1 Tri-amino-pyrimidine cyclobutenedione derivatives used as phosphatase cdc25 inhibitors
03/18/2009EP2036895A1 Hsp90 inhibitor
03/18/2009EP2035406A1 Novel substituted-1h-quinazoline-2,4-dione derivatives, preparation method thereof and pharmaceutical composition containing the same
03/18/2009EP2035401A2 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
03/18/2009EP2035370A2 Tetralin and indane derivatives and uses thereof
03/18/2009EP1689380A4 Method for treating adamts-5-associated disease
03/18/2009EP0963984B1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics
03/18/2009CN101389612A 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative
03/18/2009CN101389611A Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by vla-4
03/18/2009CN101386600A Process for producing phenylalanine derivative having quinazolinedione skeleton and intermediate for the same
03/18/2009CN100469368C Use of adatanserin for treating neurogenerative disorders
03/17/2009US7504512 BCL-X1 protein inhibitors; anticarcinogenic agents
03/17/2009US7504503 Process for producing substituted aniline compound
03/17/2009US7504502 Guanidinopyrimidinone compounds and phase change inks containing same
03/17/2009US7504432 Quaternary salt of (3-((2-(3,3-difluorocyclopentyl)-2-hydroxy-2-(4-methylphenyl)ethanoyl)oxy)-1,1-dimethylpyrrolidinium bromide; respiratory system disorders; chronic obstructive pulmonary diseases, bronchitis, asthma, emphysema, rhinitis; side effect reduction; inhalants; muscarinic receptor antagonists
03/17/2009US7504410 such as N-[3-[[5-bromo-4-[[3-[[[1-(trifluoromethyl)cyclobutyl]carbonyl]amino]propyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide; Chks (checkpoint kinases), Akts (protein kinases B) and Pdks (phosphoinositide-dependent kinases) inhibitors; antiproliferative agents
03/17/2009US7504408 Quinzoline derivatives for use in the treatment of cancer
03/17/2009US7504405 Mitotic kinesin inhibitors
03/17/2009US7504397 mTOR inhibitor compounds
03/17/2009US7504396 Substituted heterocyclic compounds and methods of use
03/17/2009US7504208 Deblocking, deprotecting 18F-labeled tracer; ion exchange chromatography; cartrigdes, radiopharmaceutical kits; diagnostic positron emission tomography; pharmacokinetics
03/17/2009CA2639658A1 Design and synthesis of novel tubulin polymerization inhibitors: benzoylphenylurea (bpu) sulfur analogs
03/17/2009CA2429263C Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia
03/17/2009CA2340405C Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same
03/12/2009WO2009032703A1 2- (het) arylamino-6-aminopyridine derivatives and fused forms thereof as anaplastic lymphoma kinase inhibitors
03/12/2009WO2009032668A2 2 -biphenylamino-4 -aminopyrimidine derivatives as kinase inhibitors
03/12/2009WO2009030715A1 Arylsulfonylaminomethylphosphonic acid derivatives, the preparation thereof and the use thereof as pharmaceutical compositions
03/12/2009WO2009030467A2 Saturated and insaturated bi- or tricyclic aryloxyacetamide derivatives and their use as fungicides
03/12/2009WO2009029998A1 Retrometabolic compounds
03/12/2009WO2009010139A3 Quinazolinamide derivatives
03/12/2009WO2009006086A3 A new process for preparing 2-(3-{6-[2-(2,4-dichlorophenyl)-ethylamino]-2-methoxypyrimidin-4-yl}-phenyl)- 2-methylpropionic acid
03/12/2009WO2008155668A3 Heteroarylamide pyrimidone compounds
03/12/2009US20090069563 Rosuvastatin intermediates and their preparation
03/12/2009US20090069562 Process for the preparation of alfuzosin
03/12/2009US20090069354 Deuterium-enriched gemcitabine
03/12/2009US20090069353 Deuterium-enriched ambrisentan
03/12/2009US20090069327 Compounds and compositions as protein kinase inhibitors
03/12/2009US20090069320 Substituted 4-Amino-Quinazoline Compounds with Metabotropic Glutamate Receptor Regulating Activity and Uses Thereof
03/12/2009US20090069310 Anti-inflammatory medicaments
03/12/2009US20090069309 Prostaglandin analogs
03/12/2009US20090069282 Alkyne compounds with mch antagonistic activity and medicaments comprising these compounds
03/12/2009US20090068273 Prophylaxis of respiratory disorders such as asthma; composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent; 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol or salt
03/12/2009US20090066231 Electroluminescent device
03/12/2009US20090065739 Liquid crystal compound having chloronaphthalene moiety, liquid crystal composition, and optical device
03/12/2009CA2698511A1 Substituted pyrimidinyl-amines as protein kinase inhibitors
03/12/2009CA2698486A1 Arylsulfonylaminomethylphosphonic acid derivatives, the preparation thereof and the use thereof as pharmaceutical compositions
03/12/2009CA2696824A1 Compounds and compositions as kinase inhibitors
03/12/2009CA2696320A1 Novel fungicides
03/11/2009EP2033950A1 Substituted tetracycline compounds
03/11/2009EP2033647A1 Agent against psychosocial stresses
03/11/2009EP2033637A1 Therapeutic or prophylactic agent for leukemia
03/11/2009EP2032554A1 Piperidinyl pyrimidine derivatives
03/11/2009EP2032543A1 2-anilino-4-aminoalkyleneaminopyrimidines
03/11/2009EP2032542A2 Heterocyclic aspartyl protease inhibitors
03/11/2009EP1631533B1 Novel process for stereoselective reduction of beta-ketoesters
03/11/2009EP1485364B1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
03/11/2009EP1456182B1 Pyrimidine derivatives as modulators of insuline-like growth factor-1 receptor (igf-i)
03/11/2009EP1349840B1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
03/11/2009EP0976722B1 Benzamidine derivatives
03/11/2009CN101384562A 2-substituted pyrimidines and their use as pesticides
03/11/2009CN101384561A Reduction of 5-(aryl-diazenyl)-4,6-dihalo-pyrimidine
03/11/2009CN101384554A Pyridine-2-carboxamide derivatives
03/11/2009CN101381347A Miazines compounds, preparation method and use thereof
03/11/2009CN100467447C Thioamide compound or its salt and cytokine production inhibitor containing the same
03/10/2009US7501512 Chemical compounds
03/10/2009US7501510 N,N'-disubstituted thiourea ligand, when complexed with palladium forms a catalyst useful for Heck reaction of arylhalides and olefins and Suzuki cross-coupling reaction of aryl halides with aryl boric acids
03/10/2009US7501429 Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents
03/10/2009US7501428 Quinazoline thiazolinones
03/10/2009US7501427 Such as N6-(4,5-dihydrooxazol-2-yl)-N4-[3-methyl-4-(6-methylpyridin-3-yloxy)-phenyl]-quinazoline-4,6-diamine; for treatment of hyperproliferative disorders such as cancer
03/10/2009US7501425 e.g. 1-Methyl-7-[4-(pyrazol-1-yl)phenylamino]pyrimido[4,5-d]pyrimidin-2(1H)-one; anticarcinogenic agents; restenosis, angiogenesis and atherosclerosis
03/10/2009US7501424 4-methyl-N-(5-methylthiazol-2-yl)-3-(4-thiazol-2-yl-pyrimidin-2-ylamino)-benzamide; amidation; protein kinase inhibitor; water soluble; stability; anticancer; Chronic Myelogenous Leukemia; lung, gastric, colon, pancreatic, hepatoma, prostatic, breast, encephalophyma, bladder, cervical, lymphoma
03/10/2009US7501418 e.g. 3-[4-(2-Methyl-3-phenyl-allyl)-piperazin-1-ylmethyl]-3a,4-dihydro-3H-2,5-dioxa-1,7-diaza-dicyclopenta[a,g]naphthalene; serotonine (5-HT) reuptake inhibitor, alpha 2-adrenoceptor antagonist; antidepressant, anxiolytic agent; Parkinson's disease, eating disorders, psychosis, obesity
03/10/2009US7501417 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
03/10/2009US7501416 Quinoxaline compounds and methods of using them
03/10/2009US7501407 Amide substituted pyrimidine compound; antiarthritic agents; antiischemic agents; antidiabetic agents; inflammatory bowel disease; antiproliferative agents; antiallergens
03/05/2009WO2009029735A1 2-(substituted phenyl)-6-amino-5-alkoxy, thioalkoxy and aminoalkyl-4-pyrimidinecarboxylates and their use as herbicides
03/05/2009WO2009027450A1 Novel bradykinin b1-antagonists
03/05/2009WO2008142720A4 Quinazolin-oxime derivatives as hsp90 inhibitors
03/05/2009WO2008062276A3 Acetylene derivatives as stearoyl coa desaturase inhibitors
03/05/2009WO2008055068A3 Inhibitors of histone deacetylase
03/05/2009US20090062539 Crystals, amorphous substances or salts of methyl n-[3-(6,7-dimethoxy-2-methylaminoquinazolin-4-yl) phenyl] terephthalamic acid
03/05/2009US20090062536 Use of sulfonanilide compounds as herbicide
03/05/2009US20090062530 Substituted arylalkanoic acid derivatives and use thereof